Home / Posts Tagged "Dr Reddy’s Laboratories"

Team Marksmen Network successfully hosted the Most Preferred Workplaces 2025–26 – Healthcare, Pharma & Biotech on December 11 at Novotel Mumbai International Airport. Themed “Redefining Workplaces, Reigniting India’s Growth Story,” the day-long conference and awards ceremony brought together over 200+ senior leaders from across the

READ MORE

Event organized by Informa Markets in India to bring over 2,000 exhibitors & 50,000 industry participants from more than 120 countries under one roof.Organized by Informa Markets in India, the 18th edition of CPHI & PMEC India 2025, South Asia's largest and most influential pharmaceutical industry event, is scheduled

READ MORE

Senores Pharmaceuticals Limited (“SPL”), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (“SPI”), has signed agreements today to acquire a basket of 14 Abbreviated New Drug Applications (‘ANDAs’) from Dr. Reddy’s Laboratories and its applicable affiliates (BSE: 500124 | NSE: DRREDDY | NYSE: RDY |

READ MORE

OneSource Specialty Pharma Limited today announced the appointment of three new non-executive independent directors to its Board — Dr. Claudio Albrecht, Ms. Debarati Sen and Mr. Vijay Karwal—effective February 27, 2025. The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation,

READ MORE

From Microsoft & Medtronic to WHO and Johnson & Johnson, Asia’s biggest biotechnology conference announces a diverse range of experts from technology and healthcare industries Conference to host about 50 speakers, participating across in 7 panels, 2 keynote addresses, a CEO Conclave and a

READ MORE

Leading drug makers Dr Reddy's Laboratories and Zydus Pharma are recalling bottles of a product each, in the US market, for different reasons, according to the latest report of the US health regulator. Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is

READ MORE